Mankind Pharma will finalize the allotment by May 3, 2023.
IPO Mankind Pharma: Investors in Mankind Pharma IPO can check the status of their share allotment.
Mankind Pharma IPO: Mankind Pharma’s initial share sale was subscribed 15.32 times on the last day of the offer on Thursday, helped by heavy interest from institutional buyers.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations in various acute and chronic therapeutic areas as well as a number of consumer health care products.
The IPO received bids for 42,95,12,902 shares against 2,80,41,192 shares on offer, according to NSE data.
The Qualified Institutional Buyers (QIBs) portion was subscribed 49.16 times, while the Non-Institutional Investors category was subscribed 3.80 times and Retail Individual Investors (RIIs) 92 per cent.
Mankind Pharma will finalize the allotment by May 3, 2023. If not allotted, the refund will be processed on May 4. Once allotted, the shares will be credited to your demat account. May 5th.
Shares will be listed on NSE and BSE May 8, 2023.
Refund will be credited to the bank accounts of unsuccessful investors by May 4th And the equity shares will be transferred to demat accounts by May 5.
The company’s IPO was an offer for sale (OFS) of 4,00,58,844 equity shares entirely by the promoters and other existing shareholders.
The price range for the offer was Rs 1,026-1,080 per share.
Since the IPO is purely an OFS, the company will not receive any net proceeds from the issue and the entire net proceeds will go to the selling shareholders.
The equity shares of the company will be listed on both BSE and NSE.
Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India were the managers to the offer.
Mankind IPO GMP
On April 29, Mankind shares were trading at a premium of Rs 88 above the upper band of Rs 1,080 per share in the gray market. Hence, the shares were trading at Rs 1,168 in the gray market. This indicates that the shares of the company are expected to be listed at a premium to its issue price on May 8, 2023. The premium fluctuates depending on the sentiments in the markets.
Investors in Mankind Pharma IPO can check the status of their share allotment on BSE website or IPO Registrar’s portal by following few simple steps;
- Visit the official website of BSE or Bombay Stock Exchange. The link is (https://www.bseindia.com/investors/appli_check.aspx)
- This will take you to a page called ‘Status of Issue Application’.
- Once on the page, click on the ‘Equity’ option
- From the drop-down menu that appears along with the issue name, select the option ‘Mankind Pharma’
- Write your application number on the page
- After that enter your Permanent Account Number or PAN
- Click on the captcha that says ‘I am not a robot’ and click on submit
- After clicking on the option, the allotment status details of your bid. The status will be visible only after the share allotment is finalised.
(With PTI inputs)
read all latest business news, tax news And stock market update Here
